Drug Search Results
More Filters [+]

Ornidazole

Alternative Names: ornidazole
Latest Update: 2024-05-31
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Bangladesh | Belgium | Chile | China | Colombia | Egypt | France | India | Italy | Jordan | Korea | Luxembourg | Morocco | New Zealand | Peru | Philippines | Portugal | Russia | Sri Lanka | Switzerland | Taiwan | Turkey | Ukraine | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Yangzijiang Pharmaceutical Group Hailing Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ornidazole

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Colorectal Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

COLONPREP

P3

Active, not recruiting

Colorectal Cancer

2021-07-07

Recent News Events